This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics

Register by September 19 to save $600

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
24-26 Feb, 2026
Grand Nikko Tokyo DaibaTokyo
Book Now
Menu
Book Now

Dr. Hiroshi Yamada, PhD
Head of Drug Delivery Research and Development at Nitto Denko Corporation
Speaker

Profile

Hiroshi YAMADA, Ph.D. Head of Drug Delivery Research and Development Dept. Nucleic Acid Medicine Business Div. Corporate Technology Sector Nitto Denko Corporation https://www.linkedin.com/in/hiroshi-yamada-93364121/ With over 25 years of experience in the pharmaceutical industry, engaged in pharmacology, safety assessment, early-stage development, business development, and corporate strategy. Broad expertise across small molecules, antibodies, viral vectors, and lipid nanoparticles (LNPs).

At this event

Prev
Next
Dr. Stefano Zanotti, PhD
VP, Head of Neuromuscular Research
Dyne Therapeutics

See Hiroshi at TIDES Asia: Oligonucleotide & Peptide Therapeutics

Book Now